BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19528469)

  • 41. A novel experimental mouse model of peritoneal dissemination of human gastric cancer cells: analysis of the mechanism of peritoneal dissemination using cDNA macroarrays.
    Nomura H; Nishimori H; Yasoshima T; Hata F; Sogahata K; Tanaka H; Nakajima F; Ikeda S; Kamiguchi K; Isomura H; Sato N; Denno R; Hirata K
    Jpn J Cancer Res; 2001 Jul; 92(7):748-54. PubMed ID: 11473725
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of latrunculin-B on outflow facility in monkeys.
    Peterson JA; Tian B; Geiger B; Kaufman PL
    Exp Eye Res; 2000 Mar; 70(3):307-13. PubMed ID: 10712817
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibitory effects of a specific phage-displayed peptide on high peritoneal metastasis of gastric cancer.
    Bai F; Liang J; Wang J; Shi Y; Zhang K; Liang S; Hong L; Zhai H; Lu Y; Han Y; Yin F; Wu K; Fan D
    J Mol Med (Berl); 2007 Feb; 85(2):169-80. PubMed ID: 17043801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic efficacy of a paclitaxel-loaded nanofibrillated bacterial cellulose (PTX/NFBC) formulation in a peritoneally disseminated gastric cancer xenograft model.
    Akagi S; Ando H; Fujita K; Shimizu T; Ishima Y; Tajima K; Matsushima T; Kusano T; Ishida T
    Int J Biol Macromol; 2021 Mar; 174():494-501. PubMed ID: 33545180
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adenovirus-mediated calponin h1 gene therapy directed against peritoneal dissemination of ovarian cancer: bifunctional therapeutic effects on peritoneal cell layer and cancer cells.
    Ogura T; Kobayashi H; Ueoka Y; Okugawa K; Kato K; Hirakawa T; Hashimoto S; Taniguchi S; Wake N; Nakano H
    Clin Cancer Res; 2006 Sep; 12(17):5216-23. PubMed ID: 16951241
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical outcomes and prognostic factors of metastatic gastric carcinoma patients who experience gastrointestinal perforation during palliative chemotherapy.
    Kang MH; Kim SN; Kim NK; Park YI; Kim YW; Ryu KW; Lee JH; Lee JS; Park SR
    Ann Surg Oncol; 2010 Dec; 17(12):3163-72. PubMed ID: 20585878
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Latrunculin A is a potent inducer of aggregation of polymorphonuclear leukocytes.
    Oliveira CA; Chedraoui S; Mantovani B
    Life Sci; 1997; 61(6):603-9. PubMed ID: 9250716
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cathepsin B cleavable novel prodrug Ac-Phe-Lys-PABC-ADM enhances efficacy at reduced toxicity in treating gastric cancer peritoneal carcinomatosis: an experimental study.
    Shao LH; Liu SP; Hou JX; Zhang YH; Peng CW; Zhong YJ; Liu X; Liu XL; Hong YP; Firestone RA; Li Y
    Cancer; 2012 Jun; 118(11):2986-96. PubMed ID: 22006342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of latrunculin A on immunological phagocytosis and macrophage spreading-associated changes in the F-actin/G-actin content of the cells.
    Oliveira CA; Kashman Y; Mantovani B
    Chem Biol Interact; 1996 Mar; 100(2):141-53. PubMed ID: 8646787
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of peritoneal metastasis in an animal gastric cancer model by interferon-gamma and interleukin-2.
    Okamoto T; Tsuburaya A; Yanoma S; Yoshikawa T; Cho H; Takanashi Y; Noguchi Y
    Anticancer Res; 2003; 23(1A):149-53. PubMed ID: 12680206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The bisphosphonate incadronate inhibits intraperitoneal dissemination in an in vivo pancreatic cancer model.
    Takiguchi S; Nishino Y; Inoue K; Ikeda M; Kataoka Y; Matsusue K; Nishiyama K; Iguchi H
    Oncol Rep; 2012 Jul; 28(1):111-6. PubMed ID: 22484715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HZ08 reverse the aneuploidy-induced cisplatin-resistance in Gastric cancer by modulating the p53 pathway.
    Tang X; Hu G; Xu C; Ouyang K; Fang W; Huang W; Zhang J; Li F; Wang K; Qin X; Li Y
    Eur J Pharmacol; 2013 Nov; 720(1-3):84-97. PubMed ID: 24183976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adenoviral oncolytic suicide gene therapy for a peritoneal dissemination model of gastric cancer in mice.
    Imamura Y; Ishikawa S; Sato N; Karashima R; Hirashima K; Hiyoshi Y; Nagai Y; Koga Y; Hayashi N; Watanabe M; Yamada G; Baba H
    Ann Surg Oncol; 2010 Feb; 17(2):643-52. PubMed ID: 20012217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude mice.
    Saimura M; Nagai E; Mizumoto K; Maehara N; Okino H; Katano M; Matsumoto K; Nakamura T; Narumi K; Nukiwa T; Tanaka M
    Cancer Gene Ther; 2002 Oct; 9(10):799-806. PubMed ID: 12224019
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intra-peritoneal administration of paclitaxel with non-animal stabilized hyaluronic acid as a vehicle--a new strategy against peritoneal dissemination of gastric cancer.
    Yamada J; Kitayama J; Tsuno NH; Yamashita H; Miyato H; Soma D; Otani K; Kamei T; Ishigami H; Hidemura A; Kaisaki S; Takahashi K; Nagawa H
    Cancer Lett; 2008 Dec; 272(2):307-15. PubMed ID: 18768251
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The current situation and subjects of the intraperitoneal chemotherapy for peritoneal dissemination in gastric cancer].
    Hirono Y; Fujimoto D; Nagano H; Murakami M; Katayama K; Yamaguchi A
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):891-5. PubMed ID: 18633215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Intraperitoneal chemotherapy in gastric cancer patients with peritoneal dissemination].
    Hirono Y; Katayama K; Murakami M; Iida A; Yamaguchi A
    Gan To Kagaku Ryoho; 2005 Oct; 32(10):1404-9. PubMed ID: 16227738
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Actin cytoskeleton derangement induces apoptosis in renal ischemia/reperfusion.
    Genescà M; Sola A; Hotter G
    Apoptosis; 2006 Apr; 11(4):563-71. PubMed ID: 16528472
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intraperitoneal administration of an adenovirus vector carrying REIC/Dkk-3 suppresses peritoneal dissemination of scirrhous gastric carcinoma.
    Than SS; Kataoka K; Sakaguchi M; Murata H; Abarzua F; Taketa C; Du G; Yashiro M; Yanagihara K; Nasu Y; Kumon H; Huh NH
    Oncol Rep; 2011 Apr; 25(4):989-95. PubMed ID: 21249317
    [TBL] [Abstract][Full Text] [Related]  

  • 60. shRNA-mediated inhibition of PhosphoGlycerate Kinase 1 (PGK1) enhances cytotoxicity of intraperitoneal chemotherapy in peritoneal metastasis of gastric origin.
    Archid R; Zieker D; Weinreich FJ; Hönes F; Königsrainer A; Quintanilla-Martínez L; Reymond MA; Solass W
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):613-619. PubMed ID: 31980221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.